Главная
Study mode:
on
1
Introduction
2
Immunotherapy vs other therapies
3
What is immunotherapy
4
Immune system
5
Immune responses against cancer
6
PDL1 inhibitors
7
Nivolumab
8
Other clinical trials
9
Melanoma vs sarcoma
10
Two different goals
11
Is it safe
Description:
Explore immunotherapy options for treating leiomyosarcoma in this informative 34-minute video lecture by Dr. Bartosz Chmielowski from the UCLA Sarcoma Program. Gain insights into the differences between immunotherapy and other treatment approaches, understand the basics of the immune system and its responses against cancer, and learn about PDL1 inhibitors like Nivolumab. Discover ongoing clinical trials, compare the effectiveness of immunotherapy in melanoma versus sarcoma, and understand the two different goals of treatment. Delve into the safety aspects of immunotherapy and broaden your knowledge about this innovative approach to cancer treatment.

Leiomyosarcoma: Immunotherapy Clinical Trials - UCLA Sarcoma Program

University of California, Los Angeles
Add to list
0:00 / 0:00